A comparative pharmacogenomic analysis of three classic TCM prescriptions for coronary heart disease based on molecular network modeling
- 12 February 2020
- journal article
- research article
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 41 (6) , 735-744
Abstract
Traditional Chinese medicine (TCM) has evolved over several thousands of years, which has been shown to be efficacious in the treatment of ischemic heart disease. Three classical TCM prescriptions, namely Xuefu Zhuyu Decoction, Zhishi Xiebai Guizhi Decoction, and Gualou Xiebai Banxia Decoction, have been extensively used in the treatment of coronary heart disease (CHD). Based on molecular network modeling, we performed a comparative pharmacogenomic analysis to systematically determine the drug-targeting spectrum of the three prescriptions at molecular level. Wide-area target molecules of CHD were covered, which was a common feature of the three decoctions, demonstrating their therapeutic functions. Meanwhile, collective signaling involved metabolic/pro-metabolic pathways, driving and transferring pathways, neuropsychiatric pathways, and exocrine or endocrine pathways. These organized pharmacological disturbance was mainly focused on almost all stages of CHD intervention, such as anti-atherosclerosis, lipid metabolism, inflammation, vascular wall function, foam cells formation, platelets aggregation, thrombosis, arrhythmia, and ischemia-reperfusion injury. In addition, heterogeneity analysis of the global pharmacological molecular spectrum revealed that signaling crosstalk, cascade convergence, and key targets were tendentious among the three decoctions. After all, it is unadvisable to rank the findings on targeting advantages of the three decoctions. Comparative pharmacological evidence may provide an appropriate decoction scheme for individualized intervention of CHD.Keywords
This publication has 94 references indexed in Scilit:
- Interferon-Gamma Increases the Ratio of Matrix Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 in Peripheral Monocytes from Patients with Coronary Artery DiseasePLOS ONE, 2013
- Assessing salivary C-reactive protein: Longitudinal associations with systemic inflammation and cardiovascular disease risk in women exposed to intimate partner violenceBrain, Behavior, and Immunity, 2012
- Transfer of IP3 through gap junctions is critical, but not sufficient, for the spread of apoptosisCell Death & Differentiation, 2011
- Caloric restriction in leptin deficiency does not correct myocardial steatosis: failure to normalize PPARα/PGC1α and thermogenic glycerolipid/fatty acid cyclingPhysiological Genomics, 2011
- The association of bile acid excretion and atherosclerotic coronary artery diseaseTherapeutic Advances in Gastroenterology, 2010
- ABC transporters, atherosclerosis and inflammationAtherosclerosis, 2010
- Non‐genomic effects of PPARγ ligands: inhibition of GPVI‐stimulated platelet activationJournal of Thrombosis and Haemostasis, 2010
- Top-Down Lipidomics Reveals Ether Lipid Deficiency in Blood Plasma of Hypertensive PatientsPLOS ONE, 2009
- Microarray analysis of gene expression in mouse aorta reveals role of the calcium signaling pathway in control of atherosclerosis susceptibilityAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Network biology: understanding the cell's functional organizationNature Reviews Genetics, 2004